Genistein-3′-sodium sulfonate promotes brain functional rehabilitation in ischemic stroke rats by regulating astrocytes polarization through NF-κB signaling pathway

• Published in: Chemico-biological interactions Vol. 400; p. 111159
• Main Authors: Liu, Ruizhen, Yu, Yunling, Ge, Qinglian, Feng, Ruixue, Zhong, Guixiang, Luo, Li, Han, Zun, Wang, Tianyun, Huang, Cheng, Xue, Jinhua, Huang, Zhihua
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01.09.2024
• Subjects: Astrocyte polarization; Genistein-3′-sodium sulfonate; Ischemic stroke; NF-κB signaling; NF-κB signaling; Ischemic stroke; Genistein-3′-sodium sulfonate; Astrocyte polarization; Genistein-3'-sodium sulfonate
• ISSN: 0009-2797; 1872-7786; 1872-7786
• DOI: 10.1016/j.cbi.2024.111159

The activation and polarization of astrocytes are involved in neuroinflammation and brain functional rehabilitation after ischemic stroke. Our previous studies display the neuroprotective effect of genistein-3′-sodium sulfonate (GSS) in the acute phase of cerebral ischemia-reperfusion injury (CI/RI). This study aimed to investigate the brain function improvement of GSS during the recovery period after CI/RI in rats and to explore the potential mechanism from the perspective of astrocyte activation and polarization. The transient middle cerebral artery occlusion (tMCAO) rats were treated with GSS (1 mg/kg) continuously for 28 days. The behavior tests were measured to assess neurological function. The mRNA and protein expression in affected cerebral cortex were detected on day 29 after tMCAO. Our results demonstrated that GSS treatment significantly improved the spatial and temporal gait parameters in the Catwalk gait test, prolonged the time on the stick and increased the rotation speed in the rotarod test, and decreased the time to find the hidden platform and increased the time in the target quadrant in the Morris water maze test. In addition, GFAP, GBP2, C3, IL-1β protein expressions and Nos2A mRNA level were decreased, while Nrf2, BDNF, IL-10 protein expressions and Sphk1 and Nef2l2 mRNA levels increased after GSS treatment. Interestingly, GSS presented a strong binding affinity to TLR4 and suppressed the activation of NF-κB signaling. In conclusion, GSS can promote brain function recovery by inhibiting astrocyte activation and polarization to A1 phenotype, and enhancing astrocyte polarization to A2 phenotype via inactivating TLR4/NF-κB signaling, which provide a candidate compound for clinical rehabilitation therapy in the recovery period after ischemic stroke. •GSS improved cognitive function in tMCAO rats during the recovery period.•GSS enhanced motor function, motor coordination and balance in tMCAO rats during the recovery period.•GSS reduced the astrocytes polarization toward type A1 and increased toward type A2.•GSS inhibited the activation of the NF-κB signaling pathway in tMCAO rats during the recovery period.